📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Edge Therapeutics

1.1 - Company Overview

Edge Therapeutics Logo

Edge Therapeutics

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of biotechnology-driven therapies created by transforming FDA-approved drugs to address unmet acute neurological conditions.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Edge Therapeutics

Brain Scientific Logo

Brain Scientific

HQ: United States Website
  • Description: Provider of high-tech, clinical-grade neurological diagnostic devices designed to extend the reach and capability of telemedicine in neurology (teleneurology).
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Brain Scientific company profile →
Clairvoyant Therapeutics Logo

Clairvoyant Therapeutics

HQ: Canada Website
  • Description: Provider of psilocybin-based therapy solutions for Alcohol Use Disorder, including a 24-week Phase 2b clinical trial with synthetic psilocybin and two dosing sessions, a 35-hour therapist training program to support participants, and a therapist adherence monitoring program to monitor adherence to trial protocol and ethics, pursuing a speed-to-market clinical strategy.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Clairvoyant Therapeutics company profile →
NextWave Pharma Logo

NextWave Pharma

HQ: United States Website
  • Description: Provider of pharmaceutical products developed and commercialized using proprietary drug delivery technology; based in Cupertino, CA.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full NextWave Pharma company profile →
JDS Pharmaceuticals Logo

JDS Pharmaceuticals

HQ: United States Website
  • Description: Provider of specialty pharmaceutical solutions focused on developing prescription psychiatry products.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full JDS Pharmaceuticals company profile →
MAP Pharmaceuticals Logo

MAP Pharmaceuticals

HQ: United States Website
  • Description: Provider of novel inhalation therapies under development for respiratory and systemic diseases, with proprietary product candidates including Unit Dose Budesonide for pediatric asthma (children six months to eight years) and MAP0004 for migraine.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full MAP Pharmaceuticals company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Edge Therapeutics

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Edge Therapeutics

2.2 - Growth funds investing in similar companies to Edge Therapeutics

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Edge Therapeutics

4.2 - Public trading comparable groups for Edge Therapeutics

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Edge Therapeutics

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Edge Therapeutics

What does Edge Therapeutics do?

Edge Therapeutics is a provider of biotechnology-driven therapies created by transforming FDA-approved drugs to address unmet acute neurological conditions.

Who are Edge Therapeutics's competitors?

Edge Therapeutics's competitors and similar companies include Brain Scientific, Clairvoyant Therapeutics, NextWave Pharma, JDS Pharmaceuticals, and MAP Pharmaceuticals.

Where is Edge Therapeutics headquartered?

Edge Therapeutics is headquartered in United States.

How many employees does Edge Therapeutics have?

Edge Therapeutics has 1,000 employees 🔒.

When was Edge Therapeutics founded?

Edge Therapeutics was founded in 2010 🔒.

What sector and industry vertical is Edge Therapeutics in?

Edge Therapeutics is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Edge Therapeutics

Who are the top strategic acquirers in Edge Therapeutics's sector and industry

Top strategic M&A buyers and acquirers in Edge Therapeutics's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Edge Therapeutics?

Top strategic M&A buyers groups and sectors for Edge Therapeutics include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Edge Therapeutics's sector and industry vertical

Which are the top PE firms investing in Edge Therapeutics's sector and industry vertical?

Top PE firms investing in Edge Therapeutics's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Edge Therapeutics's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Edge Therapeutics's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Edge Therapeutics's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Edge Therapeutics include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Edge Therapeutics's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Edge Therapeutics?

The key public trading comparables and valuation benchmarks for Edge Therapeutics include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Edge Therapeutics for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Edge Therapeutics with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Edge Therapeutics's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Edge Therapeutics with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Edge Therapeutics's' sector and industry vertical?

Access recent funding rounds and capital raises in Edge Therapeutics's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Edge Therapeutics